vimarsana.com

Page 2 - Cell Bound Complement Activation Products News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Exagen Announces Five-Week Campaign for Lupus Awareness

Zacks Investment Research Upgrades Exagen (NASDAQ:XGN) to Hold

Exagen (NASDAQ:XGN – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Thursday, Zacks.com reports. According to Zacks, “Exagen Inc. is engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases. It developed and commercialises testing products under […]

Head-To-Head Analysis: PotNetwork (OTCMKTS:POTN) vs Exagen (NASDAQ:XGN)

Exagen (NASDAQ:XGN – Get Rating) and PotNetwork (OTCMKTS:POTN – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and profitability. Volatility and Risk Exagen has a beta of 0.72, suggesting that […]

FY2024 Earnings Estimate for Exagen Inc (NASDAQ:XGN) Issued By KeyCorp

Exagen Inc. (NASDAQ:XGN – Get Rating) – Investment analysts at KeyCorp issued their FY2024 earnings estimates for shares of Exagen in a report released on Thursday, March 24th. KeyCorp analyst P. Knight expects that the company will earn ($1.10) per share for the year. KeyCorp has a “Overweight” rating and a $20.00 price objective on […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.